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OSAS : obstructive sleep apnea syndrome 
OBST : obstruction 
DISE : Drug induced sleep endoscopy             
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m : muscle 
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MMP : Modified Mallampati Index 
SDB : Sleep Disordered Breathing 
AASM : American Academy Of Sleep Medicine 
SL  : Sleep Latency 
TST  : Total Sleep Time 
SE  : Sleep Efficiency 
TIB : Total time in bed 
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INTRODUCTION 
Obstructive sleep apnea syndrome (OSAS) is a component of sleep 
disordered breathing and this disorder is characterized by excessive snoring 
and periodic apneas, hypopneas and arousals that leads to fragmented sleep in 
a repetitive specific duration .OSAS is a disease of modern ages and 
identified as distinct entity for past 20 to 25 years .At present ,OSAS has been 
identified as a separate risk factor or an entity for increased susceptibility to 
stroke, myocardial infarction, cardiac arrhythmias, hypertension, 
dyslipidemia, insulin resistance and diabetes mellitus, depression, sexual 
dysfunction .Impairment of alertness also increases the risk of susceptible 
patients to occupational hazards and automobile accidents.  
Sleep is a “ transient state  of altered consciousness and perceptual 
disengagement from one‟s surrounding environment”. More over the sleep 
phenomenon is a active process associated with a profound physiological 
alterations involving a complex interactions and processing among various 
parts of brain especially cortical and diencephalic structures. Under normal 
circumstances, physiological systemic functions associated with sleep occur 
without any serious consequences. However in pathological states, the 
changes ensue in any of these systemic functions may present serious 
physiological risks with consequences that affect the qualitative and 
quantitative aspects of sleep and daytime functions .Henceforth majority of 
this renewed interest within the otolaryngologists has been focused on s leep 
related breathing disorder OSA and this recognition has led to a  
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Multi disciplinary approach with a creation of new medical discipline – 
Sleep medicine; with a teams made up of otolaryngologists, pulmonologists 
,neurologists, maxillofacial surgeons, and behavioral psychologists. 
HISTORICAL PERSPECTIVES 
Day time somnolence associated with obesity was first described by 
“CHARLES DICKENS” in 1837 through his writing in “The Posthumous 
Papers of the Pickwick club”  
 1956 – Drs.A.G.Bicklemann, C.S.Burwell  ,and colleagues described 
“Pickwickian Syndrome” .  
 1970 –Elio Lugaresi‟s described completely about “OSA syndrome”.  
 1983 – Riley described cephalometric evaluation for OSA.  
 1985 – Fujita described “Uvulopalatopharyngoplasty (UPPP)”.  
 1986 – Colin Sullivan ,a young Australian medical researcher 
developed nasal “Continuous Positive Airway Pressure”.  
1990-dr.murray john developed ESS 
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Charles Dickens  
CLASSIFICATION OF OBSTRUCTIVE SLEEP-RELATED 
BREATHING DISORDERS; 
SNORING 
Defined as “sound generated by the vibration of pharyngeal soft 
tissues”. Usually it is more during inspiration than expiration; and it may also 
present as a separate symptom without any association to day time sleepiness.  
UPPER AIRWAY RESISTANCE SYNDROME: 
UARS is a recent entity which “describes patients with symptoms of 
OSA and PSG evidence of sleep fragmentation with AHI<5 without 
oxyhemoglobin saturation” 
OBSTRUCTIVE SLEEP APNEA SYNDROME 
OSA is defined as “five or more respiratory events (apneas,hypopneas, 
or RERAs) in association with excessive daytime somnolence,waking with 
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gasping, choking, or breath-holding, or witnessed reports of apneas, loud 
snoring or both”. 
RESPIRATORY EVENTS DEFINITIONS 
APNEA 
“Cessation of airflow for at least 10 seconds”.  
HYPOPNEA 
“Reduction in airflow (≥30%) at least 10 seconds with ≥4% Oxy-
hemoglobin  desaturation or reduction in airflow (≥50%) at least 10 seconds 
with ≥3% oxy-hemoglobin desaturation or an EEG arousal”.  
RESPIRATORY EFFORT-RELATED AROUSAL (RERAS) 
“Sequence of breaths for at least 10 seconds with increasing respiratory 
effort or flattening of nasal pressure waveform leading to an arousal from 
sleep when the sequence of breaths does not meet the criteria for an apnea or 
hypopnea”. 
APNEA-HYPOPNEA INDEX 
It is calculated as “number of apneas and  hypopneas per hour of total 
sleep time”. 
Normal : AHI<5 
Mild OSA : AHI 5-15 
Moderate OSA : AHI 16-30 
Severe OSA : AHI>30” 
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OBESITY HYPOVENTILATION SYNDROME 
It is defined as “combination of obesity (BMI>30Kg/m2) ,hypoxemia 
during sleep,hypercapnia during daytime resulting from hypoventilation”  
TYPES OF APNEA 
OBSTRUCTIVE 
It is expressed as “respiratory event with continued thoracoabdominal 
effort in the setting of partial or complete airflow cessation”.  
CENTRAL 
It is the “lack of thoraco abdominal effort in the setting of partial or 
complete airflow cessation”.  
MIXED 
“This usually begins as central events and end up with a thoraco -
abdominal effort in cessation of airflow”. Hence it is mixture of  Both central 
and obstructive respiratory events.  
CENTRAL APNEA INDEX 
 “Number of central apneas per hour of total sleep time”.  
MIXED APNEA INDEX 
Expressed as “number of mixed apneas per hour of total sleep time”.(1)  
 ANATOMY OF SNORERS AND APNEIC PATIENTS 
In OSA patients, there is collapse of different pharyngeal soft  tissue 
structures especially that of velopharynx, oropharynx, and /or  hypopharynx 
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inaddition to soft palate vibrations .Based on the different  sites of 
pharyngealcollapse, “OSA patients are structurally classified as:  
1) Type-1: narrowing or collapse in the retropalatal (velopharyngeal) 
region alone 
2) Type-2: narrowing or collapse in both retropalatal and retroglossal 
regions . 
3) Type-3: narrowing or collapse in the retroglossal region alone”.  
PHYSIOLOGY OF SLEEP 
Sleep is a temporary state of unconsciousness that can be interrupted 
by external stimuli and it is regulated by RAS. 
THEORIES OF SLEEP 
PASSIVE THEORY 
Discharge from RAS during prolonged hours of wakefulness leaads to 
fatigue of RAS thereby inducing sleep. 
ACTIVE THEORY 
1) Serotonin from raphe fibres inhibits  RAS therby promoting sleep 
2) Melatonin from pineal gland inhibits reticular activating system 
thereby promoting sleep 
NEUROTRANSMITTERS INHIBITING SLEEP 
1) Histamine acts on posterior hypothalamus to promote alertness and 
wakefulness thereby inhibiting sleep. 
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2) Aspartate and glutamate acts on thalamo cortical neurons leading to 
cortical activation thereby promoting sleep.  
3) ACH/GABA acts on telencephalon leading to wakefulness.  
4) PGE2 release causes wakefulness.(2) 
SLEEP PROMOTING NEUROTRANSMITTERS: 
1) Serotonin inhibits posterior hypothalamus and RAS and promotes 
sleep. 
2) Melatonin inhibits suprachiasmatic nucleus to promote sleep.  
3) PGD2 released from medial preoptic area of hypothalamus promotes 
sleep. 
4) Increased adenosine concentration has found to promote sleep.  
GENESIS OF NREM SLEEP  
NREM Sleep is produced by stimulation of three subcortical centers  
1) “Low frequency stimulation of diencephalic sleep zone in posterior 
hypothalamus and anterior thalamic nucleus promotes NREM sleep”  
2) “Low frequency stimulation of medullary synchronizing zone in NTS 
promotes NREM sleep. 
3) Either low or high frequency stimulation of basal forebrain(preoptic 
area and diagonal band of broca)promote sleep.(2)  
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GENESIS OF REM SLEEP 
“PGO spikes due to discharge from cholinergic neurons in lateral 
pontine tegmentum promotes REM sleep” “During REM sleep there is 
increased activity in pontine area, amygdala, anterior cingulate gyrus and 
visual association areas and decreased activity in prefrontal ,parietal cortex 
and primary visual cortex.”  
EEG WAVES 
ALPHA WAVES 
 “Awake but at rest with mind wandering, eyes closed  
 8-12HZ 
 50-100 UV 
 Parieto occipital area” 
BETA WAVES 
 “18-30HZ 
 Amplitude lower 
 Frontal Region” 
THETA WAVES 
 “Hippo campus 
 4-7 HZ 
 Amplitude large” 
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DELTA WAVES 
 “<4HZ 
 Amplitude large” 
STAGES OF SLEEP 
During normal sleep, a young adult first enters  NREM sleep, asses 
through stages 1&2 spends 70-100 min in stages 3&4,sleep then lightens and 
passes to REM sleep. His cycle is repeated at intervals of every 90 min. But 
towards morning time there is more of REM sleep and less of stage 3&4 
sleep. 
STAGE-1 
 “4-5 % (Light Sleep) 
 Low Amplitude 
 High Frequency 
 Muscle Activity 
 Slows Down 
 Transition From alpha wave to theta waves”.  
STAGE-2 
 “ 45-55 % (Breathing Pattern) 
 HR Slows 
 Theta Activity 
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 Sleep spindles & K complexes” 
STAGE-3 
 “4-6 % (Deep Sleep) 
 Delta wave 
 Slow High amplitude 
 Low frequency” 
STAGE-4 
 “ 12-15 % (Very Deep Sleep) 
 Muscle Activity decreases 
 Delta Waves 
 Large marked synchronization.”  
REM SLEEP 
  “20-25% 
 Rapid, low voltage EEG activity 
 Paradoxical sleep 
 PGO Spickes 
 Hypotonicity 
 Dreams 
 80%in premature infants 
 50% in children 
 25% in adults 
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 REM NREM 
Duration 20-25% 75-80% 
Eye Mvt Rapid No 
Autonomic 
activity 
Increased fluctuation in 
BP,HR,RR 
Decreased  
Low BP, slow HR, Steady 
respiration 
Brain Activity Active Minimal 
Muscular 
activity 
Decreased Functional but less 
EEG Low voltage Passes from alpha to 
delta 
Dreaming Yes No 
OBSTRUCTIVE SLEEP-DISORDERED BREATHING 
STATIC AND DYNAMIC FORCES 
It is easy when conceptualizing the upper airway to a oversimplified 
complex interactions, but when dividing it into various forces based on static 
and dynamic components it gives a better concepts on correlation between 
sleep and breathing. The static determinants of airway size are contributed by 
the anatomical structures especially the intrinsic pharyngeal area mainly 
constructed by the craniofacial framework and upper airway soft tissue 
mass.Whereas the dynamic forces are contributed by phasic neuromuscular 
tone and dynamic airflow .And each of these forces have additional levels of 
controls, complexity ,physiology and pathology .  
Anatomical abnormalities including smaller maximal upper airway, 
increased compliance as the airway decreases in size ,more positive closing 
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pressures, and increased airway length are the known abnormal static features 
responsible for sleep disordered breathing. These abnormal static 
characteristics result in an abnormally collapsible air -column on exposure to 
the conditions of dynamic flow. 
The mechanics of upper airway collapse may be described using both a 
static model that evaluates the changes due to independent airflow system and 
also a dynamic model that evaluates the changes in respect to negative 
inspiratory pressure and airflow .Classically ,it was thought that the uppe 
rairway collapse occurs only during the inspiration when negative inspiratory 
pressure and airflow predominate .However the models state that collapse is 
not only limited to inspiration but also occurs during expiration. This critical 
event of expiratory collapse occurs when static characteristics predominate.  
BALANCE OF FORCES AND STARLING RESISTOR 
Integrating the multitude of anatomical or static forces and 
physiological processes or dynamic forces into a manageable pattern is done 
using these models. 
Balance of forces explains about the multiple forces acting on theupper 
airway system leading to their collapse or altering its size.These collapsing 
forces include tissue mass, surface adhesive forces, and negative intraluminal 
pressures. 
“Ptm = Pin – Pout = Ptissue – Pluminal” 
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Starling resistor is builded upon the concept of “Poiseuille‟s law”, and 
it describes the pattern and effect of airflow in collapsible tubes 
resemblingthe upper airway system. 
“ V = P1-P2 / R” 
Three basic clinical patterns namely normal breathing, snoring, and 
obstruction are explained by this method. 
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ANATOMY OF SOFT PALATE (VELUM): 
It is a mobile musculo aponeurotic connective tissue suspended from 
posterior part of hard palate. The lateral part of soft palate is continuous with 
palatoglossal and palate pharyngeal folds. Soft palate has two layers of 
mucosa between which there is a fibrous band called palatine aponeurosis 
which is expanded tendon of m.tensorveli palate.(3)  
During deglutition soft palate is made taut which makes the tongue to 
press against the soft palate thereby allowing food bolus to squeezed into oral 
cavity. Then soft palate is elevated postero-superiorly to press against the 
posterior pharyngeal wall by the action of m.levatorveli palate to prevent food 
entering nasal cavity. 
MUSCLES OF SOFT PALATE 
 m.tensor veli palate 
 m.levatorveli palate 
 m.uvulae 
 m.palatoglossus 
 m.palatopharyngeus 
TENSOR VELI PALATI 
It originates from “medial pterygoid plate of sphenoid, spine of 
sphenoid, cartilage of auditory tube” and it gets inserted to pa latine 
aponeurosis . It‟s main action is tensor of soft palate and opens auditory tube 
while swallowing and yawning.(4) 
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LEVATOR VELI PALATI 
It orginates from “cartilage of auditory tube and inferior surface of 
petrous part of temporal bone”, gets inserted into palatine aponeurosis. it‟s 
main action is elevation of soft palate.  
PALATOGLOSSUS 
It originates from palatine aponeurosis and gets inserted to side of 
tongue.it‟s main action is elevation of posterior part of tongue and 
approximates soft palate and tongue. 
PALATOPHARYNGEUS 
It originates from palatine aponeurosis and gets inserted into lateral 
wall of pharynx.it elevates the pharyngeal wall antero superiorly and medially 
during deglutition. 
MUSCULUS UVULAE 
It originates from palatine aponeurosis and gets inserted into mucosa of 
uvula. It acts to pull the uvula up and shorten it. It is the only intrinsic muscle 
of larynx. 
“All muscles of soft palate are innervated by pharyngeal plexus except 
m.tensorveli palate which is innervated by trigeminal nerve.”  
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PALATOPHARYNGEAL SPHINCTER(PASSAVANT’S 
MUSCLE); 
It arises from anterosuperior surface of palatine aponeurosis to blend 
with upper border of superior pharyngeal constrictor to encircle the pharynx 
as a sphincter.it acts along with palatopharyngeus and levator palate to help in 
closure of pharyngeal isthmus. (3,4).  
MUSCLES OF TONGUE 
INTRINSIC MUSCLES 
1) Superior longitudinal muscles-make dorsal  surface of tongue concave 
and shorten the length of tongue. 
2) Inferior longitudinal muscles-make dorsal surface of tongue convex 
and shorten the length of tongue. 
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3) Transversus linguae-reduce the width and increase the length of 
tongue. 
4) Verticalis linguae-increase the width of the tongue and make the dorsal 
surface concave from side to side. 
EXTRINSIC MUSCLES 
1) Styloglossus-pulls tongue upwards and backwards. 
2) Palatoglossus-muscles of both side acting together bring the 
palatoglossal arches together closing the aperture from oral cavity to 
pharynx. 
3) Genioglossus-protrudes tongue (safety muscle of tongue) 
4) Hyoglossus-depresses tongue 
“Allmuscles of tongue are supplied by hypoglossal nerve except 
palatoglossus which is supplied by cranial part of accessory nerve”.(4)  
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PATHOPHYSIOLOGY OF OSA 
 
The etiology and mechanism of airway collapse and OSA is Multi 
factorial and it is largely due to the interaction of collapsible upper airway 
with the relaxation of the pharyngeal dilator muscles. Notably, patients 
without anatomical abnormalities may also present with OSA. Obesity, soft 
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tissue hypertrophy ,  and craniofacial characteristics increases the propensity 
for OSA by increasing the extra luminal tissue pressures. The three major 
areas of obstruction are the nose, the palate and the hypopharynx . Nasal 
obstruction mainly contributes for increased airway resistance. At present, 
obesity is considered as an independent and major risk factor for sleep 
disordered breathing. Obesity contributes to OSA mainly through two 
pathological processes namely the mechanical effect of tracheal and thoracic 
traction called as „tracheal tug‟ and by the hypertrophy of genioglossus 
muscle, which is considered to be the most important muscle in maintaining 
the upper airway in OSA patients .(5)  
OSAS affects 2-5% of population.40-60 years is the most commonest 
age group affected. Males are commonly affected(M:F=2:1).Post menopausal 
women have 2-3 fold increased  risk of developing OSAS. Obesity and weight 
gain are the two most important risk factors for development of OSAS. It is a 
gradually progressive disease characterized by palatal denervation with a 
localized polyneuropathy and inflammatory cell infiltration of soft palate 
caused by snoring related vibrations and large intra luminal pressure 
differences due to obstruction. 
SYMPTOMS OF OSAS 
NOCTURNAL SYMPTOMS 
1) “Snoring 
2) Witnessed apneas 
3) Dyspnea 
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4) Drooling 
5) Dry mouth 
6) Bruxism 
7) Restless sleep/frequent arousals 
8) Gastroesophageal reflux 
9) Nocturia”(6) 
DAYTIME SYMPTOMS 
1) “Excessive day time sleepiness  
2) Morning headaches 
3) Neuro cognitive impairment 
4) Diminished quality of life 
5) Mood and personality changes 
6) Sexual dysfunction”.(6) 
COMMON FINDINGS IN OSAS 
1) Craniofacial: 
2) “Retrognathia 
3) High arched palate 
4) TMJ dislocation”(6) 
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5) Pharyngeal: 
6) “Macroglossia 
7) Erythema/edema of uvula 
8) Elongated,low lying soft palate 
9) Tonsillar pillar hypertrophy 
10) Tonsillar enlargement 
11) Retropalatal,retroglossal space restriction”(6) 
DENTAL 
 “Overjet 
 Malocclusion 
 Bruxism 
 Orthodontia” 
NASAL 
 “Asymmetric small nares  
 Inspiratory collapse of alae and internal valves  
 Septal deviation 
 Inferior turbinate hypertrophy”  
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EVALUATION OF OSAS 
POLYSOMNOGRAPHY 
    Investigation should be considered if  the  patient presents with 
persistent snoring, and at least one other associated symptom. “excessive 
daytime sleepiness, Impaired cognitive function -difficulty concentrating, 
depression, learning and memory difficulties, personality changes, and 
hyperactivity in children.  
Morning headaches, decreased libido and impotence in men impair 
work performance Cardiovascular- hypertension and insulin resistance, heart 
attack, cardiac arrhythmia, and stroke”.(7)  
PSG is the„„gold standard‟‟ for diagnosing  SDB and other sleep 
disorders.It allows “qualitative and quantitative documentation of 
abnormalities of sleep and wakefulness, sleep-wake transition, and of 
physiological function of other organ systems that are influenced by 
sleep.”(7) 
INDICATIONS OF PSG 
1) Diagnosing SDB and its treatment with CPAP 
2) Evaluation for effectiveness of alternative treatments for SDB (eg, 
dental appliances or surgical procedures) 
3) Diagnosis of sleep-related seizures and parasomnias 
4) Evaluation of erectile dysfunction with nocturnal penile tumescence 
[NPT]).(7) 
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TYPES OF PSG 
Level I-“Standard PSG with minimum of seven parameters measured 
(EEG,EOG, chin EMG,ECG, airflow,respiratory effort, and oxygen 
saturation) in a specilist unit”.  
Level II-“Comprehensive portable PSG same,except that  a heart rate 
monitor can replace the ECG and a technician is not in constant attendance”  
Level III.-“Modified portable sleep apnea testing is a cardiorespiratory 
study ,minimum of four parameters ventilation (at least two channels of 
respiratory movement, or respiratory movement and airflow), heart rate or 
ECG, and oxygen saturation”. Done at home.  
Level IV-“Continuous (single or dual) bioparameter recordings where 
devices that measure a minimum of one parameter, usually oxygen saturation 
are utilized”(7) 
Additional variables that can be measured with PSG are Body position,  
end-tidal carbon dioxide monitoring (EtCO2), 16-channel EEG 
recording for seizures, esophageal pressure monitoring (Pes),pulse transit 
time (PTT) and videography of the whole session can be taken. 
A major disadvantage in this technique is that ,breathing disturbances 
may vary from night to night within certain limits .Some sleep disorders such 
as nocturnal laryngospasm, sleep related epilepsy, and parasomnias that occur 
episodically may be missed in one-night measurement . 
 
 24 
SLEEP HYPNOGRAM 
A sleep hypnogram is a summary of the entire night‟s PSG data in a 
graphic form. It gives a good snapshot of sleep architecture, distribution of 
respiratory events, and oxygen saturation trends in different sleep stages,sleep 
position, and at different times of the study night. It is helpful to open a 
window for the hypnogram simultaneously while reviewing the PSG.  
The most important parameters measured in sleep hypnogram are:  
1) Total recording time(TRT)-“ beginning and end of recording”  
2) Total sleep time(TST)-“ actual sleep REM +NREM” 
3) Sleep period time(SPT)- “ sleep onset to final awakwning”  
4) Sleep efficiency (SE)-“ percentage of TST in total time in bed”. 
SE>85%is normal 
5) Sleep latency (SL) –“time elapsed between lights out to the first epoch 
of sleep (usually stage 1)”.  
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PLETHYSMOGRPHY 
1) Impedence plethysmography- measures the elastic recoil during 
respiration into electric impulses 
2) Magnetometry- measures magnetic changes between the two sides of 
chest 
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FLUROSCOPY 
Fluoroscopy is a readily available technique to assess dynamic airway 
anatomy and sites of obstruction in OSA patients. Somnofluoroscopy 
combines fluoroscopy with polysomnography and radiologically evaluate 
thesites of obstruction during episodes of apnea and hypopnea. Advantages of 
fluoroscopy include direct observation of obstructive sites during episodes of 
apnea, and availability of fluoroscopy in most hospitals.  
Drawbacks include high radiation dose, superimposition of 
structures,and the possible need for sedation to attain sleep during the 
procedure. Newe rdigital fluoroscopy systems require less radiation exposure 
and shorter examination times. 
MANOMETRY 
Manometry techniques use catheters in the upper airway to measure 
pressure at various sites in the upper airway. Patients who do not have frank 
apneas or hypopneas, but had symptoms of OSA, short alpha EEG arousals 
during sleep, and abnormal increases in upper airway resistance are measured 
using manometry during sleep have categorized into upper airway resistance 
syndrome. CPAP has been shown to resolve the symptoms associated with 
upper airway resistance syndrome. Both awake and asleep manometry 
measurements have been performed to identify areas at risk for collapse. In 
awake patients, externally provided negative pressure or patient provided 
negative pressure (MM) have been used to collapse the airway during 
evaluation. A sleep manometry has the significant advantages of assessing 
airway collapsibility without externally induced pressures, and of removing 
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the confounding effect of airway muscular tone. Manometry studies are 
difficult to perform in that they require precise placement of an invasive 
probe transnasally, which is poorly tolerated by many patients. Typically, a 
sleep manometry is performed in concurrent with sleep studies, and allows for 
measurement of intra thoracic pressure and respiratory drive to assist with 
identification of central apnea. 
TREATMENT OPTIONS  
Treatment options for OSA fall under three categories :  
1) Behavioural Modification 
2) Devices that can be worn  
3) Surgery  
BEHAVIOURAL MODIFICATION  
WEIGHT REDUCTION 
Weight reduction leads to improvement in lung volumes thereby 
reducing pharyngeal resistance and improves nocturnal hemoglobin 
saturation. 
SLEEP POSTURE THERAPY  
The patients are asked to sleep in lateral positions or in prone position.  
DEVICES THAT CAN BE WORN  
Positive airway pressure: 
Most effective treatment in moderate to severe grades of OSA in 
tolerant patients. It is available in many forms such as  CPAP, biPAP, 
automatically titrating PAP and demand  PAP.(8) Each delivers positive 
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pressure  through a device worn on the face, and serves as an internal 
pneumatic splint for the airway. CPAP, the most commonly used form of 
PAP, typically uses between 5 and 15 cm of water pressure to maintain airway 
patency.(8) 
Oral appliances 
Mandibular repositioning devices  advance the mandible anteriorly,  
which brings forward the  tongue and other muscles of the oropharynx   and 
hypopharynx.The position of the palate is also changed with the mandibular    
repositioning device through action of the palatoglossus muscle.   It is used 
for patients with simple snoring and mild apnea.   Patients with pre-existing 
disorders of the tempero mandibular joint and   edentulous patients are not 
considered to be good candidates for this device. As with PAP, no training of 
the airway occurs, therefore nightly use is    necessary for treatment effect.(9)  
Tongue - Retaining Device ( TRD )  
 “ It increases pharyngeal patency by pulling  the superior aspect of the 
tongue forward, away from the posterior wall of the pharynx” .(9)  
SURGICAL MANAGEMENT OF OSA 
UTILITY OF SURGERY IN OSA  
1) “By passing the obstructive area by tracheostomy  
2) eliminating the obstructive lesion in order to prevent 
soft palate  collapse in the upper airway during an 
apneic episode”  
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 Indications include 
1) “Morbidly obese patients  unable to tolerate PAP  
2) Morbidly obese patients with Pickwickian syndrome who require upper 
airway bypass and nocturnal ventilation 
3) Patients Who are unable to tolerate PAP  
4) Other Treatment options have failed”.  
Bariatric surgery is considered when 
1) BMI >  40 or  
2) BMI > 35 with significant  co-morbidities.    
UPPER AIRWAY SURGERY IN OSA PATIENTS 
INDICATIONS 
1) AHI >20 events / hour. 
2) Oxygen desaturation nadir‟>90% 
3) „Esophageal pressure more negative‟ „> -10cm H2O‟ 
4)  „Cardiovascular derangements‟ ( arryhtmias, elevated blood pressure)  
5)  „Neurobehavioural symptoms‟ (excessive daytime sleepiness)  
6) Failure of medical management   
7)  „Anatomical sites of obstruction‟ ( nose, tongue, softpalate)(10)  
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CONTRAINDICATIONS 
1) Severe pulmonary disease 
2) Morbid obesity 
3) Unstable cardiovascular disease 
4) Alcohol or drug abuse 
5) Psychiatric instability 
 “POWELL RILEY TWO PHASE SURGICAL PROTOCOL’’ 
“PHASE 1’’: 
  “nasal surgery‟ (septoplasty , turbinate reduction , nasal valve 
grafting)  
 Uvulopalatopharyngoplasty 
  „Tonsillectomy‟  
 „Mandibular osteotomy with genioglossus advancement‟  
 „Hyoid myotomy and suspension‟  
 „Temperature controlled radiofrequency‟ (TCRF)- turbinates , palate, 
tongue base.”(11) 
“PHASE 2’’ 
  „Maxillomandibular Advanced Osteotomy‟  
  „Temperature controlled radiofrequency (TCRF)‟- tongue base 
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UTILITY OF ‘’ POWELL RILEY SURGICAL PROTOCOL’’ 
 Offers a tailor made approach for each patient  
 Procedures are focused  towards specific pathology 
 Risk of over operating is reduced. (11) 
 Limited pain and reduced time for regaining well being 
 Acceptable for many  
 Improved cure rates for phase 2 surgery 
SURGICAL TREATMENT OF OSA 
Depending upon the level of obstruction various surgical options are 
available(12) 
Palatal “Z-pharyngoplasty, injection snoreplasty, Modified 
UPPP with extended Uvulopalatal flap, palatal 
implants” 
Lateral pharyngeal wall “Lateral pharyngoplasty,Expansion sphincter 
pharyngoplasty ” 
Tongue Base “Laser midline glossectomy and lingualplasty, 
tongue suspension, lingual tonsillectomy, RFVTR, 
Hypoglossal nerve stimulation”  
Epiglottis “Endoscopic epiglottectomy”  
Trachea “Temporary tracheostomy”  
CRANIOFACIAL 
ABNORMALITIES 
“MMP,HMS” 
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AIMS OF THE STUDY 
1) To identify the level of obstruction in obstructive sleep apnea patients  
2) To compare the level of obstruction seen in normal sleep cine mri with 
that of drug induced sleep endoscopy  
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MATERIALS AND METHODS 
STUDY PLACE  
Rajiv Gandhi Government General Hospital,  Chennai – 600003 
COLLABORATING  DEPARTMENT 
 Upgraded   Institute   of Otorhinolaryngology and Barnard institute of 
radiology. 
STUDY DESIGN 
Retrospective and  Prospective  study  
STUDY PERIOD 
November 2013   To  September 2015 
STUDY POPULATION 
All patients with snoring and OSA who reported to the upgraded 
Institute of Otorhinolaryngology of Madras Medical College ,during the study 
period with the fulfillment of inclusion criteria .  
INCLUSION CRITERIA 
1) Age between 20 and 50 yrs 
2) Both sexes (Male and Female) 
3) BMI <40 
4) Neck circumference  >17 inches  for men and  >16 inches for     
women 
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5) Epsworth Sleepiness Scale >10 
6) AHI>5   
EXCLUSION CRITERIA  
1) Age below 20yrs and above 50yrs 
2) Hypothroidism and other metabolic disorders  
3) BMI>40 
4) Associated craniofacial abnormalities  
INVESTIGATIONS 
1) Thyroid Function Test 
2) Polysomnography 
3) FiberopticNasopharyngoscopy 
4) DISE ( Drug induced sleep endoscopy ) 
5) Cephalometry 
6) Dynamic MRI                                           
ETHICAL COMMITTEE APPROVAL 
Institutional Ethical Committee, Government General Hospital,  Madras 
Medical College, Chennai reviewed the experimental design and protocol as 
well as the letter of information and consent form. Full approval of the board 
was granted. All patients were given information outlining the experimental 
protocol and all patients signed a consent form prior to entering the study.  
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METHODOLOGY 
This is a prospective study conducted in our institution from November 
2013 to September 2015.All patients who attend our op with the complaints of 
snoring, frequent awakening at night ,excessive day time sleepiness 
,hallucinations. choking in sleep are further evaluated.All the patients 
undergo clinical examination followed by blood investigations especially 
thyroid function test and BMI evaluation.These patients were then subjected 
to overnight polysomnography.Those patients with AHI>5 and those who 
fulfil the inclusion criteria were then subjected to dynamic MRI and DISE 
(drug induced sleep endoscopy). 
DRUG INDUCED SLEEP ENDOSCOPY 
Between November 2013 to September 2015 Patients who ful filled the 
inclusion criteria were subjected to DISE identify the level of obstruction.The 
level of obstruction in OSAS is usually at 4 levels namely velum, oropharynx, 
tonguebase and epiglottis.identifying the level of obstruction is important to 
decide the treatment plan for the patient (21,23,25,27).DISE  provides 
valuable information such as structure, pattern and degree of collapsibility .It  
also helps us to anticipate difficult intubation/extubation .After obtaining 
anesthetic fitness patient is shifted to operating room .Patient is made to lie 
supine in the operating table and iv line is secured and RL infusion is started 
.Patient is pre oxygenated with 100% o2.LMA and ET tubes kept ready if in 
any case saturation levels falls .Inj.propofol is gradually given iv for the 
patient to snore.It is started at a dose of 0.5mg/kg(18,19,20) and can be 
increased upto 1 mg/kg .Usually the total dose is <50mg.after the patient 
starts snoring surgeon who is standing at the head end of the patient 
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introduces flexible nasopharyngoscope through patients nostril and visualizes 
the upper airway to identify the level of obstruction and degree of 
collapasability.instead of iv propofol ,(22,24) iv dexmedetomidine in dose of 
0.5-1micrograms/kg can also be used to sedate the patient.(13,14,15) 
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Grade Obstruction 
1 Simple palatal flutter 
2 Single level palatal obstruction 
3 Palatal level with intermittent oropharyngeal involvement  
4 Sustained multisegmental obstruction 
5 BOT obstruction 
6 Isolated epiglottic involvement 
DYNAMIC MRI 
Between November 2013 to September 2015 35 patients who were 
diagnosed as osas fulfilling the inclusion criteria were subjected to sleep MRI 
study after obtaining proper consent.Dynamic MRI was taken in 3 positions 
(i.e ) awake,muller manuvere ,normal sleep.Patients were examined at barnard 
institute of radiology at rajiv Gandhi govt. general hospital under continuous 
supervision by a radiologist .Patients were refrained from sleep 20 hrs before 
the MRI studies and were not allowed to ingest alcohol or sedatives during 
the day of the procedure .studies were carried out at night time .Axial and 
saggital images of the upper airway at the level of velum,oropharynx, tongue 
base,hypopharynx obtained in all 3 positions .A-P and Lateral diameters of 
upper airway measured at the level of velum, oropharynx and 
hypopharynx.50% reduction in upper airway dimension from awake position 
was considered as obstruction .Continuous spo2 monitoring was done during 
the procedure .Respiratory motion was monitored by a magnetic resonance 
linked cuff placed at the rib cage level .wakefullness is documented by 
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patient‟s response to the radiologist, During muller manuevere patient is 
asked to “attempt a forceful inspiration against closed nose and mouth” which 
is opposite to valsalva manuevere and upper airway dimensions measured 
.sleepfullness is documented by snoring heared by technician and fall in spo2 
levels by atleast 4%.(30,31) 
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STATISTICAL ANALYSIS AND RESULTS 
N 
Valid 35 
Missing 0 
GENDER 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Male 27 77.1 77.1 77.1 
Female 8 22.9 22.9 100.0 
Total 35 100.0 100.0  
77.1% Population in the study were male patients (27/35)  
22.9% population in the study were females (8/35). 
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AHI 
N 
Valid 35 
Missing 0 
 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
Mild 2 5.7 5.7 5.7 
Moderate 11 31.4 31.4 37.1 
Severe 22 62.9 62.9 100.0 
Total 35 100.0 100.0  
In the study 5.7% were mild OSA patients (2/35). 
31.4% were moderate OSA patients (11/35). 
62.9% were severe OSA patients (22/35). 
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MEANSPO2 
N 
Valid 35 
Missing 0 
 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
Abnormal 13 37.1 37.1 37.1 
Normal 22 62.9 62.9 100.0 
Total 35 100.0 100.0  
Mean spo2<90% taken as abnormal. 
37.1% population had mean SPO2<90%. 
62.9% population had mean SPO2>90%. 
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LENGTH OF SOFT PALATE 
N 
Valid 35 
Missing 0 
 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
Normal 12 34.3 34.3 34.3 
Abnormal 23 65.7 65.7 100.0 
Total 35 100.0 100.0  
Length Of Soft Palate <3.5cm was taken as normal Length of soft 
palate >3.5 cm was taken as abnormal.  
34.3%population in the study had normal soft palate length(12/35) . 
65.7% population in the study had abnormal soft palate length(23/35) . 
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THICKNESS OF SOFT PALATE 
N 
Valid 35 
Missing 0 
 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
Normal 13 37.1 37.1 37.1 
Abnormal 22 62.9 62.9 100.0 
Total 35 100.0 100.0  
Thickness of soft palate <10mm was taken as normal  
Thickness of soft palate>10 mm was taken as abnormal. 
62.9% of the study population had abnormal soft palate thickness.  
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AGE 
N 
Valid 35 
Missing 0 
 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
Upto 30 years 4 11.4 11.4 11.4 
30 to 40 years 19 54.3 54.3 65.7 
40 to 50 years 12 34.3 34.3 100.0 
Total 35 100.0 100.0  
 
11.4% of the study population were <30 years  
54.3% of the study population were 30-40years 
34.3% of the study population were 40-50 years 
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DISE GRADING 
N 
Valid 35 
Missing 0 
 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
Palate obst 12 34.3 34.3 34.3 
Palate and 
Oro 
9 25.7 25.7 60.0 
Multi 
segment 
2 5.7 5.7 65.7 
Tongue base 4 11.4 11.4 77.1 
Epiglottis 8 22.9 22.9 100.0 
Total 35 100.0 100.0  
34.3% OF Study population belonged to grade 2 in DISE  
25.7% of study population belonged to grade 3 in DISE 
5.7% of study population belonged to grade 4 in DISE 
11.4% of study population belonged to grade 5 in DISE 
22.9% of study population belonged to grade 6 in DISE 
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LEVEL OF OBSTRUCTION IN MRI 
N 
Valid 35 
Missing 0 
 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
No 
obstruction 
3 8.6 8.6 8.6 
Single level 15 42.9 42.9 51.4 
Multi level 17 48.6 48.6 100.0 
Total 35 100.0 100.0  
In the above table 8.6%patients had no obstruction in dynamic MRI.  
42.9% patients had single level obstruction.  
48.6% patients had multilevel obstruction.  
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LEVEL OF OBSTRUCTION IN DISE 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
Single level 17 48.6 48.6 48.6 
Multi level 18 51.4 51.4 100.0 
Total 35 100.0 100.0  
 
48.6% patients had single level obstruction.  
51.4% patients had multilevel obstruction.  
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AHI - AGE CROSSTABULATION 
 
Age 
Total 
Upto 30 
years 
30 to 40 
years 
40 to 50 
years 
AHI 
Mild Count 0 1 1 2 
% within 
AHI 
.0% 50.0% 50.0% 100.0% 
Moderate Count 3 6 2 11 
% within 
AHI 
27.3% 54.5% 18.2% 100.0% 
Severe Count 1 12 9 22 
% within 
AHI 
4.5% 54.5% 41% 100.0% 
Total 
Count 4 19 12 35 
% within 
AHI 
11.4% 54.3% 34.3% 100.0% 
CHI-SQUARE TESTS 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 4.822a 4 .306 
Likelihood Ratio 4.779 4 .311 
Linear-by-Linear Association 1.126 1 .289 
N of Valid Cases 35   
a. 6 cells (66.7%) have expected count less than 5. The minimum 
expected count is .23 
The above table shows thatof the 2 patients in mild OSA group 50% 
belong to 30-40 yrs and another 50% belongs to 40-50 yr age group. 
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Of  11 patients with moderate OSA 27.3%(3)belong to 20-30 
yrs,54.5%(6)belong to 30-40 yrs and  18.2%(2) belong to 40-50 yrs. 
Of 22 patients with severe OSA 4.5%(1)belong to 20=30 
yrs,54.5%(12)belong to 30-40 yrs 41%belong to 40-50 yrs. 
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MEANSPO2 – AGE 
CROSSTAB 
 
Age 
Total 
Upto 30 
years 
30 to 40 
years 
40 to 50 
years 
MEAN 
SPO2 
Abnormal Count 3 6 4 13 
% within 
MEANSPO2 
23.1% 46.2% 30.8% 100.0% 
Normal Count 1 13 8 22 
% within 
MEANSPO2 
4.5% 59.1% 36.4% 100.0% 
Total 
Count 4 19 12 35 
% within 
MEANSPO2 
11.4% 54.3% 34.3% 100.0% 
CHI-SQUARE TESTS 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 2.782a 2 .249 
Likelihood Ratio 2.706 2 .258 
Linear-by-Linear Association 1.141 1 .285 
N of Valid Cases 35   
a. 3 cells (50.0%) have expected count less than 5. The minimum 
expected count is 1.49.  
Of 13 patients who had mean spo2 <90% 23.1%(3) belonged to <30 
yrs,46.2%(6) belonged to 30-40 yrs 30.8%(4) belonged to 40-50 yrs. 
Of 22 patients who had mean spo2>90% 4.5%(1) beloned to <30 
yrs,59.1(13) belonged to 30-40 yrs,36.4%(8) belonged to 40-50 yrs 
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LENGTH OF SOFT PALATE – AGE 
CROSSTAB 
 
Age 
Total 
Upto 30 
years 
30 to 40 
years 
40 to 50 
years 
Length of 
soft palate 
Normal Count 1 9 2 12 
% within 
Length of 
soft palate 
8.3% 75.0% 16.7% 100.0% 
Abnormal Count 3 10 10 23 
% within 
Length of 
soft palate 
13.0% 43.5% 43.5% 100.0% 
Total 
Count 4 19 12 35 
% within 
Length of 
soft palate 
11.4% 54.3% 34.3% 100.0% 
CHI-SQUARE TESTS 
3 cells (50.0%) have expected count less than 5. The minimum 
expected count is 1.37. 
of 12 patients who had normal soft palate length(<3.5cm) 8.3%(1) 
belonged to <30 yrs,75%(9) belonged to 30-40 yrs,16.7%(2) belonged to 40-
50 yrs. 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 3.250a 2 .197 
Likelihood Ratio 3.405 2 .182 
Linear-by-Linear Association .924 1 .336 
N of Valid Cases 35   
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Of 23 patients who had abnormal soft palate length 13%(3) belonged to 
<30 yrs,43.5%(10) belonged to 30-40 yrs,43.5%(10) belonged to 40-50 yrs. 
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THICKNESS OF SOFT PALATE - AGE 
CROSSTAB 
 
Age 
Total Upto 
30 
years 
30 to 
40 
years 
40 to 
50 
years 
Thickness 
of soft 
palate 
Normal Count 2 6 5 13 
% within 
Thickness of 
soft palate 
15.4% 46.2% 38.5% 100.0% 
Abnormal Count 2 13 7 22 
% within 
Thickness of 
soft palate 
9.1% 59.1% 31.8% 100.0% 
Total 
Count 4 19 12 35 
% within 
Thickness of 
soft palate 
11.4% 54.3% 34.3% 100.0% 
CHI-SQUARE TESTS 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square .640a 2 .726 
Likelihood Ratio  .635 2 .728 
Linear-by-Linear Association .000 1 .988 
N of Valid Cases 35   
3 cells (50.0%) have expected count less than 5. The minimum 
expected count is 1.49. 
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0f 13 patients who had normal soft palate thickness (<1cm)15.4%(2) 
belonged to <30 yrs,46.2%(6) belonged to 30-40 yrs,38.5%(5) belonged to 
40-50 yrs. 
Of 22 patients who had abnormal soft palate thickness 9.15%(2) 
belonged to <30 yrs,59.1%(13) belonged to 30-40 yrs 31.8%(7) belonged to 
40-50 yrs. 
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GRADING – AGE 
CROSSTAB 
 
Age 
Total Upto 30 
years 
30 to 40 
years 
40 to 50 
years 
Grading 
Palate obst Count 1 7 4 12 
% within 
Age 
25.0% 36.8% 33.3% 34.3% 
Palate and 
Oro 
Count 2 6 1 9 
% within 
Age 
50.0% 31.6% 8.3% 25.7% 
Multi 
segment 
Count 0 2 0 2 
% within 
Age 
.0% 10.5% .0% 5.7% 
Tongue 
base 
Count 0 2 2 4 
% within 
Age 
.0% 10.5% 16.7% 11.4% 
Epiglottis Count 1 2 5 8 
% within 
Age 
25.0% 10.5% 41.7% 22.9% 
Total 
Count 4 19 12 35 
% within 
Age 
100.0% 100.0% 100.0% 100.0% 
CHI-SQUARE TESTS 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 8.294a 8 .405 
Likelihood Ratio 9.727 8 .285 
Linear-by-Linear Association 1.729 1 .189 
N of Valid Cases 35   
14 cells (93.3%) have expected count less than 5. The minimum 
expected count is .23. 
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Of 4 patients in upto 30 yrs age group 25%(1) had grade 2 obstruction 
in DISE,50%(2) had GRADE 3 obst,25%(1) had grade 6 obstruction.  
Of 19 patients in 30-40 yrs age group grade 2 obst-36.8%(7),grade 3-
31.6%(6)grade 4-10.5%(2),grade 5-10.5%(2),grade 6-10.5%(2) 
Of 12 patients in 40-50 yrs age group grade 2 obst-33.3%(4),grade 3-
8.3%(1),grade 5-16.7%(2),grade 6-41.7%(5). 
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MEANSPO2 - GENDER CROSSTABULATION 
 
Gender 
Total 
Male Female 
MEAN 
SPO2 
Abnormal Count 10 3 13 
% within Gender 37.0% 37.5% 37.1% 
Normal Count 17 5 22 
% within Gender 63.0% 62.5% 62.9% 
Total 
Count 27 8 35 
% within Gender 100.0% 100.0% 100.0% 
 
Of 27 males 63%(17) had spo2>90% 
Of 8 females 62.5%(5) had spo2>90% 
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AHI - GENDER CROSSTABULATION 
 
Gender 
Total 
Male Female 
AHI 
Mild Count 1 1 2 
% within Gender 3.7% 12.5% 5.7% 
Moderate Count 6 5 11 
% within Gender 22.2% 62.5% 31.4% 
Severe Count 20 2 22 
% within Gender 74.1% 25.0% 62.9% 
Total 
Count 27 8 35 
% within Gender 100.0% 100.0% 100.0% 
CHI-SQUARE TESTS 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 6.386a 2 .041 
Likelihood Ratio 6.293 2 .043 
Linear-by-Linear Association 5.590 1 .018 
N of Valid Cases 35   
3 cells (50.0%) have expected count less than 5. The minimum 
expected count is .46. 
From the above table there is a clear significance between AHI and 
gender. 
Males have severe OSA (75%) compared to females.  
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LENGTH OF SOFT PALATE – GENDER 
CROSSTAB 
 
Gender 
Total 
Male Female 
Length of  
soft palate 
Normal Count 11 1 12 
% within Gender 40.7% 12.5% 34.3% 
Abnormal Count 16 7 23 
% within Gender 59.3% 87.5% 65.7% 
Total 
Count 27 8 35 
% within Gender 100.0% 100.0% 100.0% 
Of 27 males in the study 59.3%(16) had soft palate length>3.5cm 
Of 8 females in the study 87.5% (7) had soft palate length >3.5cm 
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THICKNESS OF SOFT PALATE – GENDER 
CROSSTAB 
 
Gender 
Total 
Male Female 
Thickness  
of  
soft palate 
Normal Count 10 3 13 
% within Gender 37.0% 37.5% 37.1% 
Abnormal Count 17 5 22 
% within Gender 63.0% 62.5% 62.9% 
Total 
Count 27 8 35 
% within Gender 100.0% 100.0% 100.0% 
CHI-SQUARE TESTS 
 Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .001a 1 .981   
Continuity 
Correctionb 
.000 1 1.000 
  
Likelihood Ratio .001 1 .981   
Fisher's Exact Test    1.000 .645 
Linear-by-Linear 
Association 
.001 1 .981 
  
N of Valid Cases 35     
a. 1 cells (25.0%) have expected count less than 5. The minimum 
expected count is 2.97. 
b. Computed only for a 2x2 table 
63% of males had soft palate thickness>1cm. 
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LEVEL OF OBSTRUCTION IN MRI – GENDER 
CROSSTAB 
 
Gender 
Total 
Male Female 
Level of  
obstruction in  
MRI 
No obstruction Count 3 0 3 
% within Gender 11.1% .0% 8.6% 
Single level Count 11 4 15 
% within Gender 40.7% 50.0% 42.9% 
Multi level Count 13 4 17 
% within Gender 48.1% 50.0% 48.6% 
Total 
Count 27 8 35 
% within Gender 100.0% 100.0% 100.0% 
CHI-SQUARE TESTS 
 Value Df Asymp. Sig. (2-sided) 
Pearson Chi-Square 1.017a 2 .601 
Likelihood Ratio 1.680 2 .432 
Linear-by-Linear Association .245 1 .621 
N of Valid Cases 35   
a. 4 cells (66.7%) have expected count less than 5. The minimum 
expected count is .69. 
48.1% males (13) had multilevel obstruction in dynamic MRI.  
50% females (4) had multilevel obstruction in MRI.  
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LEVEL OF OBSTRUCTIN IN DISE – GENDER 
CROSSTAB 
 
Gender 
Total 
Male Female 
Level of  
obstructin in  
DISE 
Single level Count 13 4 17 
% within Gender 48.1% 50.0% 48.6% 
Multi level Count 14 4 18 
% within Gender 51.9% 50.0% 51.4% 
Total 
Count 27 8 35 
% within Gender 100.0% 100.0% 100.0% 
CHI-SQUARE TESTS 
 Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .008a 1 .927   
Continuity 
Correctionb 
.000 1 1.000 
  
Likelihood Ratio .008 1 .927   
Fisher's Exact Test    1.000 .620 
Linear-by-Linear 
Association 
.008 1 .928 
  
N of Valid Cases 35     
a. 2 cells (50.0%) have expected count less than 5. The minimum 
expected count is 3.89. 
b. Computed only for a 2x2 table 
51.9% males had multilevel obstruction in DISE. 
50% females had multilevel obstruction in DISE. 
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DISCUSSION 
The study was started with the aim of comparing the levels of 
obstruction in dynamic MRI and DISE in OSA and snoring patients. The 
study population chosen was scrutinized with proper implementation of  the 
inclusion criteria. The confounding factors like other systemic  disorders are 
excluded.   
REVIEW OF LITERATURE 
1.Marais  compared “ the presence or absence of snoring and its site of 
generation between a group of 205snorers and another of 126 non-snorers. 
Snoring was produced at nasendoscopy in 45.3% of non-snorers but could not 
be produced in 18.1% of snorers. There was no significant difference in the 
site of sound production between the two groups and although the noise 
produced by the non snoring group was quieter, this difference was not 
significant”.(19) 
2.Abdullah et al. “suggested that a clear establishmentof the site of 
obstruction is crucial for subsequent treatment planning”. Video sleep 
nasendoscopy (VSE) is probablythe most accurate assessment of the situation 
and also  helps in identifying the situation that needs correction.(31) 
3.Berry et al.  conducted “ a prospective cohort study involving 107 
patients divided into two groups. The twogroups of patients were matched for 
their Body Mass Index (BMI). The first group consisted of 53 patients with a 
history suggestive of obstructive sleep apnea. The second group consisted of 
54 patients with a partner-confirmed history of no snoring. These patients 
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were undergoing anesthesia for other reasons. Both groups of patients were 
free of associated otorhinolaryngological symptoms. The main outcome 
measure was assessment of production of snoring or obstruction in patients 
with no documented history of snoring when sedation was administered as 
part of genera lanesthesia using TCI with propofol. Both groups contai ned 
similar numbers of males and females but there was a predominance of males 
in the snoring group whereas females were predominant in the non snoring 
group.All patients in the symptomatic (snoring) group snored or obstructed at 
different concentrations of propofol. There was no statistically significant 
difference(P = 0.401) in the distributions of concentrations of propofol at 
which snoring started between men and women.In comparison, all patients in 
the asymptomatic (nonsnoring)group could not be induced to snore or obstruct 
at incremental levels of propofol and this was clearly significant statistically ( 
P < 0.001)”.(15) 
4.oliver M. vandervekan et al  “conducted a study to identify the 
possible predictive value of drug-induced sleep endoscopy (DISE) in 
assessing therapeutic response to implanted upper airway stimulation (UAS) 
for obstructive sleep apnea (OSA) and concluded that the absence of palatal 
Complete concentric collapse during DISE may predict therapeutic success 
with implanted UAS therapy.”(32) 
5.Yuji suto et al. observed the usefulness of cine mri in OSAS.Fifteen 
patients with sleep apnea and five healthy volunteers underwent ultrafast MR 
imaging while awake and during sleep . Sequential midline sagittal images of 
the pharynx were obtained and displayed in the cine mode Patients with sleep 
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apnea were found to have sites of pharyngeal abnormality that were not 
present in healthy volunteers. Nine sites of narrowing in seven patients (47%) 
were detected with the patient awake; 21 sites of obstruct ion in 13patients 
(87%) were diagnosed with the patient asleep. Six patients showed only one 
obstruction, and seven had several obstructions.(29)  
6.Anacelia Faria et al “conducted a prospective study of thirty-two 
patients with a polysomnographic diagnosis of OSA. All patients were 
submitted to MR imaging in order to obtain high-definition anatomical 
sagittal sequences during wakefulness and during sleep induced with 
Propofol. An area was defined on the sagittal plane in the midline of the 
pharynx. This region was called pharyngeal mid plane (PMP) area. A 
significant difference in PMP area (mm2) was observed between wakefulness 
and induced sleep in each patient (p < 0.000001).  
 The patients with OSA suffer a significant reduction of 75,5 % in the 
area of the pharynx during induced sleep compared to wakefulness.”(30)  
RESULTS 
Out of 35 patients in the study 29 patients had same levels of 
obstruction in both dynamic MRI and DISE. There is 82.8% correlation 
between dynamic MRI and DISE in identifying levels of obstruction. 
Of the 6 patients who had different results in MRI and DISE 3 patients 
had no obstruction in Dynamic MRI but found to have obstruction at VELUM 
in DISE. 
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ONE patient who had tongue base obstruction in Dynamic MRI had 
tongue base and epiglottis level obstruction in DISE. 
ONE patient had obstruction in velum and epiglottis in Dynamic MRI 
but had obstruction only in velum level in DISE. 
ONE patient had obstruction at oropharynx in Dynamic MRI was found 
to have obstruction in oropharynx and epiglottis in DISE. 
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CONCLUSION 
OSAS is a disease of modern ages and identified as distinct entity for 
past 20 to 25 years .At present ,OSAS has been identified as a separate risk 
factor or an entity for increased susceptibility to stroke, myocardial 
infarction, cardiac arrhythmias, hypertension, dyslipidemia, insulin resistance 
and diabetes mellitus, depression and sexual dysfunction. It is very important 
to identify the level of obstruction to decide the treatment protocol. Level of 
obstruction can be at velum, oropharynx, tongue base,epiglottis.This can be 
identified with Dynamic MRI and DISE. Dynamic MRI is non invasive 
procedure with no radiation hazards and gives accurate measurements of 
upper airway at velum,oropharynx and hypopharynx levels and it is done 
under normal sleep ,whereas in DISE patients are subjected to anaesthesia 
induced sleep and there can be subjective variations in quantifying the results 
.CLAUSTROPHOBIA is the main disadvantage in MRI. DISE gives equally 
good results as dynamic MRI, the only problem being subjecting the patient to 
an anasthetic procedure. Since Dynamic MRI is non invasive and gives 
accurate measurements of upper airway ,Dynamic MRI  is superior  to DISE 
in identifying the level of obstruction. In all cases planned for surgery after  
identifying level of obstruction with dynamic MRI,DISE can be done on table 
before the planned surgery to confirm the level of  obstruction  so that 
separate anesthesia for DISE can be avoided.  
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ANNEXURES 
Epworth sleepiness scale 
Patients are asked to grade from 0 to 3 their likelihood of falling asleep 
in contrast to just feeling tired in certain situations. 
The total score will be between 0 and 24. 
Level of sleepiness 
0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing 
3 = high chance of dozing 
Situations: 
1. Sitting and reading 
2. Watching TV 
3. Sitting inactive in a public place (theater, meeting) 
4. As a passenger in a car for 1 h without a break 
5. Lying down to rest in the afternoon 
6. Sitting and talking someone 
7. Sitting quickly after lunch (without alcohol) 
8. In a car while stopped in traffic 
  
 
 
PROFORMA 
Name :                                                                                            Date : 
Age :                                                                                               Ip / Op no : 
Sex : 
Occupation : 
Presenting complaints : 
History of presenting complaints : 
S.no. Complaints yes no duration 
1. History of snoring    
2. History of sleep awakening / insomnia    
3. History of excessive day time sleepiness    
4. History of impaired cognitive function    
5. History of Hallucinations    
6. History of increased weight gain    
7. History of choking in sleep    
8. History of nasal obstruction    
9. History of mouth breathing    
 
Past history :  Diabetes mellitus / Hypertension / Epilepsy / Asthma / 
Jaundice / previous history of accidents  
Personal history : Diet , appetite , smoking , alcohol , chronic drug intake , 
bowel and bladder habits 
 
 
Family history   :  married / unmarried 
General examination  : 
Built : 
Height : 
Weight : 
 
BMI : 
Neck circumference : 
Waist circumference : 
Temperature ; 
Pallor : 
Cyanosis : 
Jaundice : 
Pedal edema : 
 
Vitals ; 
Pulse :          BP :            Respiratory rate : 
 
Systemic examination : 
Respiratory system : 
Cardiovascular system : 
Central nervous system : 
 
ENT Examination : 
Throat : 
Oral cavity : 
Gums : 
Oral mucosa : 
Floor of mouth : 
 
 
Anterior 2/3rd tongue : 
Hard and soft palate : 
 
MALLAMPATI score : 
Oropharynx : 
Antr. Pillar : 
Postr. Pillar : 
Tonsil : 
Posterior pharyngeal wall : 
 
Indirect laryngoscopy : 
Posterior 1/3rd tongue : 
Vallecula : 
Epiglottis : 
Vocal cords and mobility : 
Posterior pharyngeal wall : 
 
Nose : 
External contour : 
Antr. Rhinoscopy : 
Postr. Rhinoscopy : 
 
Ear : 
Pinna : 
External auditory canal : 
Tympanic membrane : 
 
  
 
 
 
Neck : 
Laryngeal contour : 
Abnormal veins / scars : 
Accessory muscles of respiration : 
 
Investigations : 
Blood investigations : 
Thyroid functions test : 
Diagnostic nasal endoscopy : 
Video direct laryngoscopy : 
x-ray Skull :  Anteroposterior 
                      Lateral 
x-ray chest : 
 
Patient name : 
Diagnosis : 
Management :  
• Investigations  
• Anesthesia 
• Procedure  
  
 
 
PATIENT CONSENT FORM 
 
Title of the Project  :   A COMPARITIVE STUDY OF DYNAMIC MRI
WITH DRUG INDUCED SLEEP ENDOSCOPY IN OBSTRUCTIVE SLEEP 
APNEA PATIENTS
 
Institution    : Upgraded Institute of Otorhinolaryngology, 
     Madras Medical College, 
Chennai – 600003. 
 
Name :     Date   : 
Age  :     IP No. : 
Sex :     Project Patient No. : 
 
 The details of the study have been provided to me in writing and 
explained to me in my own language. 
 
 I confirm that I have understood the above study and had the 
opportunity to ask questions. 
 
 I understood that my participation in the study is voluntary and that  
I am free to withdraw at any time, without giving any reason, without the 
medical care that will normally be provided by the hospital being affected. 
 
 I agree not to restrict the use of any data or results that arise from this 
study provided such a use is only for scientific purpose(s). 
 
          I have been given an information sheet giving details of the study. 
 
          I fully consent to participate in the above study. 
 
 __________________   _______________       ___________ 
 Name of the subject          Signature      Date 
 
__________________   _______________       ___________ 
 Name of the Investigator         Signature      Date 
  
 
S.NO NAME AGE SEX 
POLYSOMNOGRAPHY                                               DYNAMIC MRI            DISE 
CENTRAL 
APNOEA 
OBSTRUCTIVE 
APNOEA 
HYPNOEA AHI 
MEAN 
HR 
MEAN 
SPO2 
MIN 
SPO2 
SOFT PALATE 
DIMENSIONS 
AIRWAY DIMENSIONS 
LEVEL OF 
OBSTRUTION 
LEVEL OF 
OBSTRUCTION 
GRADING 
LENGTH THICK AWAKE MULLER SLEEP 
AP LAT AP LAT AP LAT 
1. MAHALAKSHMI 35 F 64 93 134 44.6 62.3 87 76 4.5 1.2 13 8.9 6.8 0.7 12.1 3.5 velum, 
oro 
Velum 
,oro 
4 
14.7 14.3 5.6 4.3 6.7 5.4 
14.5 12.4 11.4 13.5 11.3 12.5 
2. MASTHAN BASHA 34 M 8 29 76 34.1 85.5 97 91 4 1.01 10.9 7.8 3.8 2.6 4.5 3.5 velum velum 2 
8.9 14.3 4.5 7.8 5.4 8.6 
13.5 12.7 6.8 4.5 7.5 5.4 
3. KUMARAN 38 M 22 76 184 41.1 75.5 94 82 3.5 1.09 17.4 14 13.3 6.5 14.5 7.6 Velum, 
oro 
Velum, 
oro 
3 
14.5 12.3 7.6 4.5 8.7 6.6 
13.5 13.4 8.6 6.5 9.6 5.8 
4. PRABHU 36 M 43 90 48 51.5 77.6 93 73 2.9 0.9 10.1 16.3 12.4 15.5 13.4 16.7 Single  
oro 
Multiple 
Oro, 
epiglottis 
6 
8.3 13.4 4.5 6.7 6.7 4.5 
13 24 17.8 23.4 7.8 11.5 
5. PALANIVEL 37 M 9 7 146 28.5 81 92 78 3.4 1.2 4.5 7.8 0 0 1 0.5 Single 
velum 
velum 2 
5.8 8.9 3.4 7.5 3.5 7.8 
28 29 18.8 14.6 17.4 12.3 
6. SHANKAR 38 M 13 171 161 47.7 68.9 93 81 3.5 0.9 8.3 10.6 3.8 2.8 4.2 3.5 Velum, 
oro 
Velum, 
oro 
3 
12.5 4.6 0 0 0 0 
19.6 14.8 17.4 10.2 14.8 11.2 
7. SRINIVAS 30 M 37 260 223 59.1 81.3 86 58 2.6 0.8 4.5 9.8 0.3 0.2 1.2 0.6 velum velum 2 
4.2 9.7 7.6 5.6 4.5 4.6 
24 22 18.3 14.4 17.8 12.7 
8 JINCE 32 M 12 102 121   32 81.3 92 86 2.4 1.1 8.1 10 4.5 3.8 4.7 3.9 Multiple Velum 
oro 
Velum, 
oro 
4 
11 3.5 0 0 0 0 
19 14 17 10 14 11.2 
9. KUMARA KRISHNAN 41 M 55 110 454 81.8 60 77 51 3.8 1 3.9 8.5 0 0 1.2 0.5 Single velum velum 2 
 
 
3.9 8.2 3.4 7.5 3.5 7.8 
24 22 18.8 14.2 17.8 12.2 
10. PRASATH 35 M 12 102 128 32.6 69.4 92 86 4.2 1.1 3.7 8.9 0 0 1 0.9 Single velum velum 2 
3.9 8.2 3.4 7.5 3.5 7.8 
24 22 18 14 17 12 
11. MADHESWARAN 48 M 74 64 254 59.8 87.9 91 79 3 0.9 13.7 11.7 5 9.7 6.4 8.6 Multiple Velum 
oro EPI 
Velum, 
Oro EPI 
6 
8.3 13.2 6.8 6.8 7.6 8.8 
14.6 9.8 1.3 1.5 1.9 2.4 
12. SOUNDARI 27 F 4 30 125 23.7 96.3 84 83 2.9 1 9.7 10.1 9.6 7.5 9.5 8.5 Single ORO ORO 3 
7.9 13.4 5.6 7.7 4.7 6.6 
14 26 9.8 22.4 8.8 21.3 
13. VIJAY 28 M 34 28 214 25.4 67.5 93 81 4 1.2 10.1 16.3 12.4 15.5 13.4 16.7 No Obstruction Velum 2 
10 13.9 12.6 8.9 11.5 9.7 
13 24 17.8 23.4 16.9 21.9 
14. RAMAMURTHY 37 M 22 88 125 33.1 96.5 90 68 4.5 1.1 8.1 10 4.5 3.8 4.7 3.9 Multiple Velum 
oro 
Velum, 
Oro 
3 
11 3.5 0 0 0 0 
19 14 17 10 14 11.2 
15. ELLAPPAN 39 M 5 114 271 42 100.2 81 60 2.5 0.4 13.2 17.4 12.3 15.4 13.1 16.3 No Obstruction Velum 2 
14.4 10.5 12.6 8.8 11.2 9.5 
S.NO NAME AGE SEX 
POLYSOMNOGRAPHY                                               DYNAMIC MRI            DISE 
CENTRAL 
APNOEA 
OBSTRUCTIVE 
APNOEA 
HYPNOEA AHI 
MEAN 
HR 
MEAN 
SPO2 
MIN 
SPO2 
SOFT PALATE 
DIMENSIONS 
AIRWAY DIMENSIONS 
LEVEL OF 
OBSTRUTION 
LEVEL OF 
OBSTRUCTION 
GRADING 
LENGTH THICK AWAKE MULLER SLEEP 
AP LAT AP LAT AP LAT 
18.4 25.6 17.7 23.8 16.3 21.2 
16. DEEPAK KUMAR 42 M 27 85 116 32.4 74.5 91 86 4.4 0.9 3.7 8.9 0 0 1 0.9 Single velum velum 2 
3.9 8.2 3.4 7.5 3.5 7.8 
24 22 18 4 17 12 
17. KUMAR 49 M 43 29 259 44.9 73.8 93 79 3.8 1 21 22 20.3 21.6 21.1 23.4 Tongue base Tongue base 5 
17.4 19.8 9.4 7.8 10.2 6.4 
 SURESH KUMAR 39 M 90 85 232 48.8 84.7 86 67 2.7 0.9 13.2 13.5 5 5.5 6.5 7.2 Multiple Velum 
EPI 
SINGLE 
VELUM 
2 
12.1 12.1 4.9 8.5 5.2 7.8 
14.7 15.8 1.2 1.3 2.3 3.5 
19. THANGARAJ 44 M 7 52 81 15.1 78.8 95 83 5 1.3 16 24 14 16 15 15.4 Single Tongue 
Base 
Tongue Base and 
EPI 
6 
9.1 13.6 0 0 1.3 1.2 
21 38 7 35 9.8 24 
20. THIRUNAVUKARASU 42 M 12 250 164 48 76.2 86 64 4 1.2 23 21 12 7 13.4 8 Multiple Velum 
oro 
Velum, 
Oro 
3 
12 19 5.4 8.6 6.8 9.7 
16 15 11 12 10.5 11.6 
21. SARASWATHY 29 F 51 58 132 22.9 83.5 86 65 3.6 0.8 12 13 0 0 1.3 1.2 Multiple Velum 
oro 
Velum, 
Oro 
3 
14.6 17.7 3.1 5.6 3.2 6.6 
16 25.7 15.4 24.3 14.5 22.5 
22. DEEPANRAJ 26 M 4 37 367 46.4 81.3 87 49 3.75 1.02 12 19 5.5 10 6.2 9.8 Multiple Velum 
oro EPI 
Velum, 
Oro EPI 
6 
20 7 0 0 1.5 1.3 
18 17 6 0 5 0.5 
23. KANDASAMY 49 M 59 34 239 43.7 59.3 95 88 3.9 1.06 12 21 0.3 0.7 1.2 1 Multiple Velum 
oro EPI 
Velum, 
Oro EPI 
6 
8 14 4 3 3.5 3 
12 9 6 4.5 5.4 6 
24. LOGANATHAN 36 M 4 12 102 27.9 73 91 81 2.5 1.4 10.5 11.6 11 9 13.2 10 Single epi EPI 6 
14 6.9 13 5.8 14 7 
14 24 3 2 5 6.3 
25. NAGARAJAN 41 M 17 392 210 67 68.2 81 71 3.6 1.2 13 18 0 0 1.3 1.2 Multiple Velum 
EPI 
Velum EPI 6 
13 9 9 9 10.5 10.3 
16 31 0 0 1.2 1.4 
26. MURUGAN 40 M 14 318 339 56.4 78.8 84 62 3.7 1.38 17 28 0 0 1.3 1.2 Multiple Velum 
oro 
Velum, 
Oro 
3 
19 15.8 6.9 11.5 7.4 13.5 
15.3 34 14 31 16 34 
27. RAJESH 33 M 4 8 177 15.7 74.9 97 95 2.5 0.8 13 17 12 15 13 16 No Obstruction Velum 2 
14 10 12 8 11 9 
18 25 17 23 16 21 
28. SRINIVASAN 42 M 6 51 223 24.1 73.6 92 84 3.9 1.4 17.9 22.6 0 0 1.2 1.2 Single velum velum 2 
 
 
15.3 9 11.2 7.2 10.5 6.8 
15 19 12 15.4 14 16.4 
29. RAVICHANDRAN 40 M 8 29 118 22.1 82.3 91 79 4.4 1.5 5.5 12 2 7 3 5 Multiple Velum 
oro 
Velum, 
Oro 
3 
9.9 13 4.5 7.5 3.8 6.8 
12 17.7 10 13 11 12.3 
30. SARASWATHY 38 F 34 28 117 25.4 72.5 92 85 5.2 1.2 12.9 20.4 0 0 1.2 1.4 Single velum velum 2 
 12.9 9 6 7.2 5.4 6.5 
S.NO NAME AGE SEX 
POLYSOMNOGRAPHY                                               DYNAMIC MRI            DISE 
CENTRAL 
APNOEA 
OBSTRUCTIVE 
APNOEA 
HYPNOEA AHI 
MEAN 
HR 
MEAN 
SPO2 
MIN 
SPO2 
SOFT PALATE 
DIMENSIONS 
AIRWAY DIMENSIONS 
LEVEL OF 
OBSTRUTION 
LEVEL OF 
OBSTRUCTION 
GRADING 
LENGTH THICK AWAKE MULLER SLEEP 
AP LAT AP LAT AP LAT 
14 22.8 11.1 21.7 12 21.4  
31. DINESH 32 M 61 219 582 79.2 101.8 74 48 4.2 1.1 8.1 10 4.5 3.4 4.3 3.6 Multiple Velum 
oro 
Velum, 
Oro 
3 
11 3.5 0 0 0 0 
19 14 17 12 14 11.2 
32. CHRISTY NIRMALA 43 F 3 15 142 17.8 83.8 96 80 3.6 1.3 13.1 13.5 5 5.5 6.4 7 Multiple Velum 
EPI 
Velum EPI 6 
12.1 12.1 4.6 8.4 5.3 7.8 
14.3 15.8 1.2 1.3 2.3 3.5 
33. KRISHNAVENI 34 F 8 29 76 14.1 85.5 97 93 3.8 1 21 22 20.3 21.6 21.1 23.4 SINGLE 
TONGUE 
BASE 
SINGLE 
TONGUE BASE 
5 
17.6 19.8 9.6 7.3 10.6 6.4 
21 37.4 7.4 35.2 9.6 25 
34. ARUNA 41 F 12 102 121 32 81.3 92 86 4.4 1.2 3.7 8.9 0 0 1.3 0.7 Multiple velum 
and tongue 
base 
Multiple 
velum,tongue 
base 
5 
4.8 8.6 3.8 7.9 3.5 7.8 
24.6 38 7 35 9.8 24.8 
35. PREMA 40 F 4 12 112 27.9 73 93 81 5 1.3 16 24 14 16 15 14.5 Single tongue 
base 
Single tongue 
base 
5 
 9.1 13.6 2.2 2.6 4.6 4.8 
21 38 7 35 9.87 24 
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MASTER CHART KEY 
AHI : Apnea Hypopnea Index 
OSA : Obstructive Sleep Apnea 
DISE : Drug Induced Sleep Endoscopy 
AP : Antero Posterior 
LAT : Lateral 
V : Velum 
Oro : Oropharynx 
Epi : Epiglottis 
Min. SPO2 : Minimum SPO2 
Mean HR : Mean Heart Rate 
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